<DOC>
	<DOCNO>NCT00483704</DOCNO>
	<brief_summary>The purpose study assess safety efficacy telcagepant ( MK-0974 ) acute treatment multiple migraine attack without aura . Primary hypothesis study telcagepant superior placebo , measure proportion participant pain freedom , pain relief , pain freedom consistency , pain relief consistency , absence photophobia , phonophobia , nausea 2 hour post-dose .</brief_summary>
	<brief_title>Multiple Attacks Study Compare Efficacy Safety MK-0974 With Placebo Acute Migraine ( MK-0974-031 )</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>History migraine within past year 1 8 moderate severe migraine attack per month past 2 month last 4 72 hour untreated Use acceptable contraception throughout study Able complete study questionnaire ( ) paper diary Limit consumption grapefruit juice one 8 ounce glass day Pregnant breastfeeding expect become pregnant study Difficulty distinguish his/her migraine attack tension interval headaches A history mostly mild migraine attack migraine usually resolve spontaneously less 2 hour More 15 headachedays per month take medication acute headache 10 day month past 3 month Greater 50 year old age migraine onset Previously take telcagepant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>multiple attack moderate severe migraine headache</keyword>
</DOC>